Histamine-2 Receptor Antagonist [EPC]

298543 reported adverse events

Drugs of this class: FAMOTIDINE CIMETIDINE FAMOTIDINE, CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE NIZATIDINE FAMOTIDINE, CALCIUM CARBONATE, AND MAGNESIUM HYDROXIDE IBUPROFEN AND FAMOTIDINE RANITIDINE FAMOTIDINE TABLET, FILM-COATED FAMOTIDINE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE CHEWABLE TABLET LORATADINE

These side effects are most commonly reported by patients taking drugs of the Histamine-2 Receptor Antagonist [EPC] class:

# Side effect Count
0 BREAST CANCER 24886
1 PROSTATE CANCER 22142
2 COLORECTAL CANCER 17545
3 RENAL CANCER 16235
4 BLADDER CANCER 13538
5 NAUSEA 10752
6 INCORRECT DOSE ADMINISTERED 10570
7 CHRONIC KIDNEY DISEASE 10466
8 DRUG INEFFECTIVE 10212
9 FATIGUE 10007
See all common reactions for Histamine-2 Receptor Antagonist [EPC]

Drugs of the Histamine-2 Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COLORECTAL CANCER 17545 0.3775
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 355 0.3721
2 RENAL CANCER 16235 0.3562
3 SMALL INTESTINE CARCINOMA 718 0.3528
4 HEPATIC CANCER 6585 0.3149
5 NEPHROGENIC ANAEMIA 1347 0.3141
6 OESOPHAGEAL CARCINOMA 8312 0.3128
7 HYPERPARATHYROIDISM SECONDARY 680 0.3002
8 PROSTATE CANCER 22142 0.2979
9 APPENDIX CANCER 252 0.2954
See all enriched reactions for Histamine-2 Receptor Antagonist [EPC]